![PHT-427 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第1页](http://file4.renrendoc.com/view/23461833496ca32751a3b44ac4031693/23461833496ca32751a3b44ac40316931.gif)
![PHT-427 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第2页](http://file4.renrendoc.com/view/23461833496ca32751a3b44ac4031693/23461833496ca32751a3b44ac40316932.gif)
![PHT-427 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第3页](http://file4.renrendoc.com/view/23461833496ca32751a3b44ac4031693/23461833496ca32751a3b44ac40316933.gif)
![PHT-427 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第4页](http://file4.renrendoc.com/view/23461833496ca32751a3b44ac4031693/23461833496ca32751a3b44ac40316934.gif)
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPHT-427Cat. No.: HY-12063CAS No.: 1191951-57-1分式: CHNOS分量: 409.61作靶点: Akt作通路: PI3K/Akt/mTOR储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 50 mg/mL (122.07 mM; Need ultrasonic)Mass Solvent1
2、 mg 5 mg 10 mg Concentration制备储备液1 mM 2.4413 mL 12.2067 mL 24.4135 mL5 mM 0.4883 mL 2.4413 mL 4.8827 mL10 mM 0.2441 mL 1.2207 mL 2.4413 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶
3、液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.10 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (6.10 mM); Clear solutionBIOLOGICAL ACTIVITY1/3 Master of Small Molecules 您边的抑制剂师www.MedChemE物活性 PHT-427种 Akt 和 PDPK1 双重 抑制剂,与 Akt 和
4、 PDPK1 中的 PH 结构域有亲和性,Ki 分别为 2.7 M 和5.2 M。IC50 & Target Akt PDPK12.7 M (Ki) 5.2 M (Ki)体外研究 The effects of PHT-427 on cell signaling are investigated by RPPA using a panel of 86 antibodies tophospho- and non-phosphorylated signaling protein related to PtdIns-3-K/PDPK1/Akt signaling in PC-3prostate cel
5、ls where PtdIns-3-K/PDPK1/Akt signaling is activated because of homozygous PTEN mutation.After 16 hours, a reduction is observed in phospho-Ser241-PDPK1 phospho-Thr308-Akt by both 10 M PH-427 and 0.1 M Wortmannin. Finally, phospho-Ser657-protein kinase C (PKC) and total SGK1 are decreasedby treatmen
6、t with both PHT-427 and Wortmannin. These results suggest that at 10 M PHT-427 inhibits bothAkt and PDKP1. The BxPC-3 and MiaPaCa-2 pancreatic cancer cell lines are probed by Western blottingfollowing up to 24 hr exposure to 10 M PHT-427, which is below the IC50 for cell growth inhibition of around3
7、0 M, to determine the effects of PHT-427 on of the PtdIns-3-K/PDPK1/Akt signaling pathway components1.体内研究 Mice with BxPC-3 pancreatic, MCF-7 breast or A-549 NSCL cancer xenografts are administered PHT-427, orits analogs with a C-4, C-6 or C-8 alkyl chain by oral gavage twice a day for 10 days. The
8、results show thatPHT-427 has the greatest antitumor activity with the C-8 chain analog having less activity, and analogs with aC-4 or C-6 chain very little activity. All further antitumor studies are conducted using compound PHT-427.Plasma levels of PHT-427 following oral administration to mice of a
9、 dose of 200 mg/kg show rapidabsorption, without a lag phase, Cmax is 8.2 g/mL 1 hr following dosing, and the elimination half-life is 1.4hr with a terminal PHT-427 concentration of 0.1 g/mL 10 hr after dosing. The plasma concentration of PH-427 is above the level which gave inhibition of Akt and PD
10、PK1 signaling in cells of 10 M (4 g/mL) for atleast 3 hr 1.PROTOCOLCell Assay 1 Panc-1 cells stably transfected with green fluorescent protein (GFP) tagged Akt or PDKP1 PH domains areserum starved in phenol red free growth medium on glass-bottom 96-well imaging plates for 16 hours. Theyare then trea
11、ted with PHT-427 at 1, 5, and 10 M or PI-103 for 4 hr, and stimulated with 50 ng/mL IGF-1 for10 min. Images are taken before and after IGF-1 treatment using an IN Cell Analyzer 1000 instrument with aNikon Plan Fluor ELWD 20X/0.45 objective loaded and using a 300msec exposure time 1.MCE has not indep
12、endently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Female C57Bl/6 mice are administered PHT-427 as a single oral dose of 200 mg/kg. The mice are killed atdifferent times (3 mice at each time point), blood collected into heparinized tubes and p
13、lasma prepared andstored frozen at -80C. For assay 0.2 mL plasma is mixed with 0.2 mL of 0.1 M sodium phosphate buffer, pH4.0, and extracted for 1 hr by inversion with 1 ml ethyl acetate. After centrifugation 0.8 mL of the organic layeris removed, evaporated under N2 and redissolved in 0.2 mL ethano
14、l and 10 L injected onto a WatersQuattro Ultima tandem mass spectrometer using a Phenomenex Luna 3.0 m, 2.050 mm C8 analytical2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEcolumn with detection and quantification by multiple reaction monitoring with the mass spectrometeroperating in electrospray
15、positive ionization mode.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 J Funct Foods. 2019 Feb.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Meuillet EJ, et al. Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent proteinkinase 1 pleckstrin homology domain inhibitor. Mol Canc
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年患者隐私保护协议与策划
- 2025年企业销售人员招聘合同范例
- 2025年企业人员临时借调合同范文
- 2025年居民安置过渡性协议
- 2025年个人流转养殖水面使用权协议
- 2025年共享发展市场拓展协议
- 2025年产业园区企业使用条款协议
- 2025年医疗设备更新协议文本
- 2025年医院食堂后勤服务合同标准格式
- 农业合作社土地使用权入股框架协议
- 学习解读2025年印发《教育强国建设规划纲要(2024-2035年)》课件
- 全过程造价咨询服务的质量、进度、保密等保证措施
- 县城屠宰场建设可行性研究报告
- 25学年六年级数学寒假作业《每日一练》
- 2025高考数学一轮复习-第8章-第3节 圆的方程【课件】
- DB3301T 1088-2018 杭州龙井茶栽培技术规范
- 环保行业深度研究报告
- 工程机械租赁服务方案及保障措施 (二)
- 保障性住房补贴委托书范本
- DB36T 1393-2021 生产安全风险分级管控体系建设通则
- 公益捐助活动影响力评估方法
评论
0/150
提交评论